Prothena Corp. Plc (PRTA)
9.03
-0.06
(-0.66%)
USD |
NASDAQ |
Feb 19, 16:00
8.75
-0.28
(-3.10%)
Pre-Market: 08:56
Prothena EPS Diluted (Quarterly) : -0.6788 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amarin Corp. Plc | -0.3701 |
| Jazz Pharmaceuticals Plc | 4.081 |
| Iterum Therapeutics Plc | -0.196 |
| GH Research Plc | -0.226 |
| Cosmo Pharmaceuticals NV | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.54M |
| Revenue (Quarterly) | 2.415M |
| Total Expenses (Quarterly) | 38.96M |
| Enterprise Value | 164.32M |
| Gross Profit Margin (Quarterly) | 60.95% |
| Profit Margin (Quarterly) | -1.51K% |
| Earnings Yield | -57.70% |
| Normalized Earnings Yield | -52.94 |